Increasing Investment in Healthcare and Biotechnology to Provide Boost to Mass Spectrometry Market

Introduction

Mass spectrometry market is expected to grow at a significant rate in the forecast period of 2019–2026. Mass spectrometry provides increased sensitivity over other analytical systems owing to superior specificity and lower background intrusion. Additionally, it can also identify existence of certain compounds and its molecular weights. It provides chemical data and data about isotopic abundance of elements in comparatively shorter time span.

Segmental insights

Mass spectrometry market is segmented on the basis of technology and application.

Based on technology it is segmented as hybrid mass spectrometry, single mass spectrometry and other mass spectrometry. Hybrid mass spectrometry is further sub-segmented into triple quadrapole, quadrapole and fourier transform mass spectrometry and single mass spectrometry is sub-segmented into ion trap, quadrapole, and time-of-flight. On the basis of application, it is segmented as pharmaceutical, biotechnology, industrial chemistry, environmental testing, food & beverage testing, and other applications.

Regional insights

Geographically, the global mass spectrometry market is segmented into four regions: North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).

North America is expected to dominate the mass spectrometry market. this is owed the region’s strong presence in chemical manufacturing and in access to superior technology. Additionally, there are many research institutes in the region, especially in USA, which are active in research in areas of healthcare and biotechnology. Europe too is expected to witness significant growth in this market. this is owed to the significantly higher exports of packaged medicaments from Europe. Mass spectrometry is used in the biotechnology and in healthcare sectors and the rise in these sectors in these regions is expected to have a positive impact on this market.

Asia Pacific too is expected to witness considerable growth in this market owing to setting up of stringent regulations in the food and beverage sector keeping in mind the growing population and rising health concerns by the consumption of food and beverages. LAMEA is expected to witness healthy growth in this market.

Competitive Players

1. BrU.K.er Corporation
2. Danaher Corporation
3. JEOL Ltd.
4. Rigaku Corporation
5. Thermo Fisher Scientific, Inc.
6. Agilent Technologies, Inc.
7. Waters Corporation
8. Leco Corporation
9. PerkinElmer Inc.
10. Sciex (Danaher Corporation)
11. Shimadzu Corporation
12. Bruker Corporation
13. Hitachi High-Technologies Corporation
14. PerkinElmer, Inc.
15. SCIEX (Danaher Corporation)

Recent Developments

Recent Developments

• January 2024- Thermo Fisher Scientific, a leading provider of analytical instruments, announced the launch of their next-generation mass spectrometry system called "Orbitrap Fusion X." According to the company's press release, this new system offers unprecedented sensitivity, resolution, and speed, allowing researchers to analyze complex samples with greater accuracy and efficiency. The Orbitrap Fusion X is designed to cater to the growing demand for advanced mass spectrometry solutions in various fields, including proteomics, metabolomics, and pharmaceutical research.
• April 2024- Researchers at MIT have utilized 3D printing technology to create a miniature ionizer, an essential element of a mass spectrometer. The novel miniature ionizer has the potential to eventually provide a cost-effective, in-house mass spectrometer for health monitoring.

Segmentation

1. By Product
   1. Instruments
   2. Consumables & Service
2. By Technology
   1. Quadrupole Liquid Chromatography-Mass Spectrometry
   2. Gas Chromatography- Mass Spectrometry (GC- MS)
   3. Fourier Transform-Mass Spectrometry (FT-MS)
   4. Time-of-Flight Mass Spectrometry (TOFMS)
   5. Matrix Assisted Laser Desorption/Ionization- Time-of-Flight Mass Spectrometry (MALDI- TOF)
   6. Magnetic Sector Mass Spectrometry
   7. Others
3. By Application
   1. Proteomics
   2. Metabolomics
   3. Lipidomics
   4. Glycomics
   5. Others
4. By End User
   1. Government & Academic Institutions
   2. Pharmaceutical & Biotechnology Companies
   3. Others